Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

CYTOKINETICS INC Director's Dealing 2020

Dec 16, 2020

30870_dirs_2020-12-15_2ce3ac92-4d9c-4db1-8c86-68fd58653379.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: CYTOKINETICS INC (CYTK)
CIK: 0001061983
Period of Report: 2020-12-15

Reporting Person: GAGE L PATRICK (Director)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2020-12-15 Common Stock M 7716 $12.96 Acquired 28520 Direct
2020-12-15 Common Stock S 7716 $21.0003 Disposed 20804 Direct

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2020-12-15 Non-Qualified Stock Option (right to buy) $12.96 M 7716 Disposed 2021-01-03 Common Stock (7716) Direct

Holdings (Non-Derivative)

Security Shares Ownership
Common Stock 1850 Indirect